Vaccines, Attenuated

4 trials

Sponsors

Finlay Institute, Finlay Institute of Vaccines (IFV)

Conditions

Cholera diseasecholera infection

Phase 2

Phase Ib-IIb trial of the live oral cholera vaccine 638 in adult volunteers in Mozambique.

Active, not recruitingRPCEC00000051

Finlay InstituteCholera disease

Start: 2006-07-31Target: 120Updated: 2026-09-14

Phase I-II study of live oral cholera vaccine 638 in healthy adult volunteers in Cuba.

Active, not recruitingRPCEC00000053

Finlay InstituteCholera disease

Start: 2005-02-21Target: 48Updated: 2026-09-14

Phase 3

CV638 ability to protect against homologous Vibrio cholerae 3008 virulent strain

Active, not recruitingRPCEC00000228

Finlay Institute of Vaccines (IFV)cholera infection

Start: 2017-03-06Target: 120Updated: 2026-09-14

Unknown Phase

Challenge study to determine the protective efficacy of a single oral dose of the attenuated 638 strain.

Active, not recruitingRPCEC00000072

Finlay InstituteCholera disease

Start: 2003-01-29Target: 27Updated: 2026-09-14